Grants per year
Personal profile
About
Katherine R. Tuttle, MD, FASN, FACP, FNKF, is Executive Director for Research at Providence Inland Northwest Health, Regional Principal Investigator of the Institute of Translational Health Sciences and Professor of Medicine at the University of Washington. She oversees a regional network of 17 clinical research centers and chairs the research Regional Executive Council for the University of Washington. Dr. Tuttle earned her medical degree and completed her residency in Internal Medicine at Northwestern University in Chicago. She was a fellow in Metabolism and Endocrinology at Washington University in St. Louis. Her Nephrology fellowship training was performed at the University of Texas Health Science Center in San Antonio.
Dr. Tuttle’s major research interests are in diabetes and chronic kidney disease. As a clinical and translational scientist, she has published over 350 original peer-reviewed articles. Early in her career, her first independently awarded research grant produced a landmark study elucidating physiological principles underlying glomerular hyperfiltration in humans with diabetes. This foundational work led to a number of subsequent physiological and pre-clinical studies that laid a foundation for new therapeutic targets in clinical trials. She has seen that work to the finish line over more than three decades to help deliver SGLT2 inhibition as the most impactful therapy to-date to reduce risks of kidney failure, cardiovascular events, and death in persons with and without diabetes. Dr. Tuttle has also been a leading investigator across the translational arc for other breakthrough therapies, including incretins and anti-inflammatory agents. She led the original clinical trial that elevated glucagon-like peptide-1 receptor agonists to potential therapeutics for chronic kidney disease, which is being tested in ongoing trials. She leads the Center for Kidney Disease Research, Education and Hope (CURE-CKD) Registry of real-world data for chronic kidney disease, diabetes, prediabetes, and hypertension from nearly 4 million health system patients. In sum, her collective work has shaped the “pillars of therapy“ approach to chronic kidney disease in a most fundamental manner across the spectrum of scientific discovery, clinical trials, and population level implementation.
Dr. Tuttle is Chair of the Diabetic Kidney Disease Collaborative for the American Society of Nephrology. She served on the inaugural Board of Directors for the Kidney Health Initiative and has chaired numerous working groups and committees for organizations including the National Institutes of Health, the American Society of Nephrology, the International Society of Nephrology, Kidney Disease Improving Global Outcomes, the National Kidney Foundation, and the American Diabetes Association. Dr. Tuttle has received many honors and awards including the John P. Peters Lifetime Achievement Award from the American Society of Nephrology, the Medal of Excellence from the American Association of Kidney Patients, the Garabed Eknoyan Award from the National Kidney Foundation, the YWCA Woman of Achievement Award in Science, and two University of Washington Outstanding Clinical Faculty Awards.
Education/Academic qualification
University of Texas Health Science Center at San Antonio
1986 → 1988
Washington University in St. Louis
1985 → 1986
Northwestern University
1982 → 1985
Northwestern University
1978 → 1982
University of California, Irvine
1974 → 1978
Research Interests
- Diabetic kidney disease
- Nutrition
- Hypertension
- Renal vascular disease
- Chronic kidney diseases
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Grants
- 6 Finished
-
Medication Intervention in Transitional Care to Optimize CKD Outcomes & Costs
Tuttle, K. & Corbett, C. L.
National Institute of Diabetes and Digestive and Kidney Diseases
09/30/11 → 08/31/14
Project: Research
-
Pathophysiology Of Glomerular Hyperfilteration In Diabetes
National Center for Research Resources
01/1/90 → 01/1/90
Project: Research
-
Role Of The Kidney In The Hypercalcemia In Malignancy
National Center for Research Resources
01/1/90 → 01/1/90
Project: Research
-
ROLE OF THE KIDNEY IN THE HYPERCALCEMIA IN MALIGNANCY
National Center for Research Resources
10/1/89 → 09/30/90
Project: Research
-
PATHOPHYSIOLOGY OF GLOMERULAR HYPERFILTERATION IN DIABETES
National Center for Research Resources
10/1/89 → 09/30/90
Project: Research
-
Accelerated Risk-Based Implementation of Guideline-Directed Medical Therapy for Type 2 Diabetes and Chronic Kidney Disease
Neuen, B. L., Tuttle, K. R. & Vaduganathan, M., Apr 16 2024, In: Circulation. 149, 16, p. 1238-1240 3 p.Research output: Contribution to journal › Comment/debate
-
Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial
Bornstein, S. R., de Zeeuw, D., Heerspink, H. J. L., Schulze, F., Cronin, L., Wenz, A., Tuttle, K. R., Hadjadj, S. & Rossing, P., 2024, (Accepted/In press) In: Diabetes, Obesity and Metabolism.Research output: Contribution to journal › Article › peer-review
Open Access -
A new era in the science and care of kidney diseases
Zoccali, C., Mallamaci, F., Lightstone, L., Jha, V., Pollock, C., Tuttle, K., Kotanko, P., Wiecek, A., Anders, H. J., Remuzzi, G., Kalantar-Zadeh, K., Levin, A. & Vanholder, R., 2024, (Accepted/In press) In: Nature Reviews Nephrology.Research output: Contribution to journal › Review article › peer-review
-
An update review of post-transplant diabetes mellitus: Concept, risk factors, clinical implications and management
Kanbay, M., Copur, S., Topçu, A. U., Guldan, M., Ozbek, L., Gaipov, A., Ferro, C., Cozzolino, M., Cherney, D. Z. I. & Tuttle, K. R., 2024, (Accepted/In press) In: Diabetes, Obesity and Metabolism.Research output: Contribution to journal › Review article › peer-review
-
Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study
Cure Glomerulonephropathy (CureGN) Study Consortium, Jan 2024, In: American Journal of Kidney Diseases. 83, 1, p. 37-46 10 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations